Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mary Jo Fitz-Gerald is active.

Publication


Featured researches published by Mary Jo Fitz-Gerald.


Life Sciences | 1995

Auditory and visual P300 event related potentials are not altered in medically and psychiatrically normal chronic marihuana users

Gloria Patrick; John J. Straumanis; Frederick A. Struve; Frances Nixon; Mary Jo Fitz-Gerald; Joseph E. Manno; Mohamad Soucair

Attempts to use Event Related Potentials, particularly the cognitive or P300 evoked potential, as measures of CNS effects of THC use have been infrequent and have produced inconsistent results. We published a pilot study in which psychiatric patient THC users had significantly prolonged auditory P300 latencies and reduced amplitudes as contrasted with non-users. Because psychiatric diagnoses and medication effects could not be controlled, we repeated the study with medically and psychiatrically normal subjects selected with extremely stringent exclusion criteria and screening procedures. P300 latency differences between THC users and controls were not detected. Using all subjects, THC users displayed reduced auditory and visual P300 amplitudes. However, when age differences between THC users and controls were removed, all significant P300 amplitude differences were removed as well. The contaminating effect of using psychiatric patients in THC research is discussed and the importance of using carefully screened normal subjects in studies of neurophysiological abuse drug effects is stressed.


Clinical Eeg and Neuroscience | 1997

Early and Middle Latency Evoked Potentials in Medically and Psychiatrically Normal Daily Marihuana Users: A Paucity of Significant Findings

Gloria Patrick; John J. Straumanis; Frederick A. Struve; Mary Jo Fitz-Gerald; Joseph E. Manno

The use of evoked potentials to study CNS effects of marihuana (THC) have produced inconsistent findings. Our previous pilot studies suggested that auditory P300 latencies and amplitudes, auditory P50 and somatosensory P30 amplitudes and brainstem auditory evoked potential latencies were altered in THC users. Because these findings were flawed by uncontrolled psychiatric diagnostic and medication variables, we undertook a controlled investigation of screened medically and psychiatrically normal THC users and controls. When age effects were controlled, THC related alterations of brain stem and both auditory and visual P300 responses could not be seen. This report extends our analyses to other auditory, somatosensory and visual evoked potentials. With the possible exception of an elevated auditory P50 amplitude, significant evoked potential correlates to daily THC use were not seen when normals were studied and age effects controlled.


Psychosomatics | 2012

Wernicke's Encephalopathy in a Patient with Hyperemesis Gravidarum

Dharmendra Kumar; Felix Geller; Lei Wang; Bart Wagner; Mary Jo Fitz-Gerald; Robert Schwendimann

The features of Wernicke’s encephelopathy have been described for over a century, usually a combination of confusion, ocular abnormalities, and ataxia. However, over the years, the vulnerable population to this disorder has been overwhelmingly described as poorly nourished alcohol dependent patients, and this has even lead to automatic thiamine administration to such patients in emergency settings. Unfortunately, this narrowed view of the at-risk patient often leads to a missed diagnosis, as evidenced in this patient who exhibited this syndrome secondary to hyperemesis gravidarum. We hope to remind providers that the disorder is secondary to a nutrional deficiency, and therefore, today’s at-risk population needs to be expanded.


Journal of Analytical Toxicology | 1995

Cannabinoids in Humans. II. The Influence of Three Methods of Hydrolysis on the Concentration of THC and Two Metabolites in Urine

Philip M. Kemp; Imad K. Abukhalaf; Joseph E. Manno; Barbara R. Manno; Dempsey D. Alford; Mary E. McWilliams; Frances Nixon; Mary Jo Fitz-Gerald; Roy R. Reeves; Mary J. Wood


Biological Psychiatry | 1999

Reduced P50 auditory gating response in psychiatrically normal chronic marihuana users: a pilot study

Gloria Patrick; John J. Straumanis; Frederick A. Struve; Mary Jo Fitz-Gerald; John Leavitt; Joseph E. Manno


Clinical Eeg and Neuroscience | 1998

Possible EEG Sequelae of Very Long Duration Marihuana Use: Pilot Findings from Topographic Quantitative EEG Analyses of Subjects with 15 to 24 Years of Cumulative Daily Exposure to THC

Frederick A. Struve; Gloria Patrick; John J. Straumanis; Mary Jo Fitz-Gerald; Joseph E. Manno


Academic Psychiatry | 2001

Psychiatry Residents’ Participation in Research

Mary Jo Fitz-Gerald; Anita S. Kablinger; Barbara R. Manno; O. S. Carter; Gloria Caldito; Stacy Smith


Clinical Eeg and Neuroscience | 1991

Longitudinal quantitative EEG findings after acute carbon monoxide exposure : two case studies

Mary Jo Fitz-Gerald; Gloria Patrick


Academic Psychiatry | 2001

The Model Psychopharmacology Curriculum

Mary Jo Fitz-Gerald; Anita S. Kablinger


Current psychiatry | 2010

The Psychotic Pot Smoker

Dharmendra Kumar; Mary Jo Fitz-Gerald; Anita S. Kablinger; Thomas Arnold

Collaboration


Dive into the Mary Jo Fitz-Gerald's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Gloria Patrick

Louisiana State University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Barbara R. Manno

Louisiana State University

View shared research outputs
Top Co-Authors

Avatar

Dempsey D. Alford

Louisiana State University

View shared research outputs
Top Co-Authors

Avatar

Dharmendra Kumar

Louisiana State University in Shreveport

View shared research outputs
Top Co-Authors

Avatar

Frances Nixon

Louisiana State University

View shared research outputs
Top Co-Authors

Avatar

Imad K. Abukhalaf

Louisiana State University

View shared research outputs
Researchain Logo
Decentralizing Knowledge